This rapid risk assessment (RRA) addresses the risk of importation of Rift Valley fever (RVF) virus (RVFV) and further spread of the virus within the European Union/European Economic Area (EU/EEA) in relation to the recent increase in cases reported on Mayotte, France.
Italy is currently experiencing four clusters of autochthonous chikungunya cases in the cities of Anzio, Latina and Rome in the Lazio region, and the city of Guardavalle Marina in the Calabria region.
Two related clusters involving autochthonous transmission of chikungunya virus have been detected in the cities of Anzio and Rome. This rapid risk assessment provides detailed event background information and assesses the threat for the European Union.
This rapid risk assessment has been produced In the context of a cluster of four confirmed cases and one probable locally-acquired case of chikungunya in Var department, in southern France.
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
This rapid risk assessment monitors the threat posed by Rift Valley fever (RVF) which has been reported in regions of eastern and southern Africa, and in most of the sub-Saharan and West African countries.
This risk assessment considers the outbreak of chikungunya on the Caribbean island of Saint Martin in early December 2013 which expanded through the Caribbean during the first half of 2014. This is the first documented autochthonous transmission of chikungunya virus in the Americas.